Valiant W.L. Mak - Concepedia

Author

Valiant W.L. Mak

Prince of Wales Hospital

Also Known As

V Mak, V. Mak, V. W. L. Mak, V.W.L. Mak, Valiant W.L. Mak, Valiant Wah Lun Mak

Publications

188

Citations

H-Index

Concepts

All Affiliations

Prince of Wales Hospital Chinese University of Hong Kong

About

Valiant W.L. Mak is an author at Prince of Wales Hospital specializing in medicine, epidemiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	133
2	Public Health	5	5	119
3	Epidemiology	5	5	119
4	Biochemistry	1	1	21
5	Diabetes	1	1	14

Valiant W.L. Mak

Publications

174

Citations

H-Index

Page 1

	Year	Citations
Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients Miao Hu, Sandra S.H. Lui, Valiant W.L. Mak, Pharmacogenetics and Genomics Metabolic SyndromeStatin TreatmentsLipid DisorderOxysterolCardiovascular Disease	2010	48
Effects of Grapefruit Juice and SLCO1B1 388A>G Polymorphism on the Pharmacokinetics of Pitavastatin Miao Hu, Valiant W.L. Mak, Ophelia Yin, Drug Metabolism and Pharmacokinetics	2012	24
Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease Miao Hu, Valiant W.L. Mak, Tom Chu, Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine Cardiometabolic RiskGenetic EpidemiologyCardiovascular PharmacologyHyperlipidemiaPharmacotherapy	2009	21
Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia Miao Hu, Valiant W.L. Mak, Brian Tomlinson Pharmacogenetics and Genomics Intronic VariantsGeneticsSimvastatin 40Genetic EpidemiologyHuman Polymorphism	2012	19
Effect of Central Obesity, Low High-Density Lipoprotein Cholesterol and C-Reactive Protein Polymorphisms on C-Reactive Protein Levels During Treatment With Rosuvastatin (10 mg Daily) Miao Hu, Michael H.K. Lee, Valiant W.L. Mak, The American Journal of Cardiology ObesityMetabolic SyndromeNutritionCardiovascular DiseaseC-reactive Protein Levels	2010	17
Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition Miao Hu, Valiant W.L. Mak, Brian Tomlinson Journal of Clinical Pharmacy and Therapeutics	2010	17
Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia Miao Hu, Valiant W.L. Mak, Brian Tomlinson Journal of clinical lipidology Metabolic SyndromeLipid DisorderApolipoprotein ECardiovascular DiseaseDiabetes	2012	14
Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects Ophelia Yin, Valiant W.L. Mak, Miao Hu, European Journal of Clinical Pharmacology Chinese SubjectsPharmacologyHuman PolymorphismClinical PharmacologyPharmacotherapy	2012	14

Page 1